ali m harandi
ali m harandi
Unknown affiliation
Verified email at gu.se
Title
Cited by
Cited by
Year
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
J Holmgren, J Adamsson, F Anjuère, J Clemens, C Czerkinsky, ...
Immunology letters 97 (2), 181-188, 2005
2152005
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection
AM Harandi, K Eriksson, J Holmgren
Journal of virology 77 (2), 953-962, 2003
2012003
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
F Wegmann, KH Gartlan, AM Harandi, SA Brinckmann, M Coccia, ...
Nature biotechnology 30 (9), 883-888, 2012
1492012
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
NPH Knudsen, A Olsen, C Buonsanti, F Follmann, Y Zhang, RN Coler, ...
Scientific reports 6 (1), 1-13, 2016
1392016
Differential roles of B cells and IFN-γ-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice
AM Harandi, B Svennerholm, J Holmgren, K Eriksson
Journal of General Virology 82 (4), 845-853, 2001
1342001
Vaccine adjuvants: a priority for vaccine research
AM Harandi, D Medaglini, RJ Shattock, WG convened by EUROPRISE
Vaccine 28 (12), 2363-2366, 2010
1132010
Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of …
AM Harandi, B Svennerholm, J Holmgren, K Eriksson
Journal of virology 75 (14), 6705-6709, 2001
1032001
Vaccine adjuvants: scientific challenges and strategic initiatives
AM Harandi, G Davies, OF Olesen
Expert review of vaccines 8 (3), 293-298, 2009
942009
Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 …
S Tengvall, A Lundqvist, RJ Eisenberg, GH Cohen, AM Harandi
Journal of virology 80 (11), 5283-5291, 2006
812006
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
J Holmgren, AM Harandi, C Czerkinsky
Expert review of vaccines 2 (2), 205-217, 2003
802003
The mucosal adjuvant effect of α-galactosylceramide for induction of protective immunity to sexually transmitted viral infection
M Lindqvist, J Persson, K Thörn, AM Harandi
The Journal of Immunology 182 (10), 6435-6443, 2009
782009
Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of …
S Raghavan, J Nyström, M Fredriksson, J Holmgren, AM Harandi
Infection and immunity 71 (12), 7014-7022, 2003
702003
CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections
AM Harandi, J Holmgren
Current opinion in investigational drugs (London, England: 2000) 5 (2), 141-145, 2004
602004
Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice
J Del Campo, M Lindqvist, M Cuello, M Bäckström, O Cabrerra, J Persson, ...
Vaccine 28 (5), 1193-1200, 2010
562010
Molecular signatures of vaccine adjuvants
T Olafsdottir, M Lindqvist, AM Harandi
Vaccine 33 (40), 5302-5307, 2015
522015
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities
D Boraschi, MA Alemayehu, A Aseffa, F Chiodi, J Chisi, G Del Prete, ...
PLoS Negl Trop Dis 2 (6), e255, 2008
472008
Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the …
C Cheng, I Bettahi, MI Cruz-Fisher, S Pal, P Jain, Z Jia, J Holmgren, ...
Vaccine 27 (44), 6239-6246, 2009
452009
Recent developments in mucosal immunomodulatory adjuvants.
AM Harandi, J Sanchez, K Eriksson, J Holmgren
Current opinion in investigational drugs (London, England: 2000) 4 (2), 156-161, 2003
402003
Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection
E Schön, AM Harandi, I Nordström, J Holmgren, K Eriksson
Journal of reproductive immunology 50 (2), 87-104, 2001
402001
Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin
J Adamsson, M Lindblad, A Lundqvist, D Kelly, J Holmgren, AM Harandi
The Journal of Immunology 176 (8), 4902-4913, 2006
372006
The system can't perform the operation now. Try again later.
Articles 1–20